EFFECT OF HUMAN MAMMARY MX-1 TUMOR ON PLASMA-FREE FATTY-ACIDS IN FASTED AND FASTED-REFED NUDE-MICE

被引:4
|
作者
LIN, C [1 ]
BLANK, EW [1 ]
CERIANI, RL [1 ]
BAKER, N [1 ]
机构
[1] JOHN MUIR CANC & AGING RES INST, 2055 N BROADWAY, WALNUT CREEK, CA 94596 USA
关键词
D O I
10.1007/BF02537055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We hypothesized that tumor-bearing (TB) nude mice, because they are reported to have no detectable, circulating tumor necrosis factor (TNF)/cachectin, would regulate their plasma free fatty acid (FFA) levels normally when fasted and refed. We compared levels of individual plasma FFA in response to fasting (24 hr) and to refeeding (for 20 hr after fasting) a fat-free, 65% sucrose diet in control, nude mice and in mice bearing 1.3 +/- 0.4 g MX-1 tumors. Total plasma FFA levels were typically high in 24-hr fasted mice [mean concentrations in mu-M +/- SE (n); controls 515 +/- 63 (6); TB, 625 +/- 63 (6)]. FFA levels were reduced by 65% in each group in response to refeeding. Each major plasma FFA species fell in response to refeeding, except arachidonate, which did not change significantly (fasted vs. fasted-refed concentrations) in either controls or TB mice. In refed mice, the molar FFA ratio of oleate to linoleate rose; however, that of oleate to arachidonate fell markedly. TB nude mice had normal appetites. We conclude that all species of FFA were mobilized from adipose tissue in a normal manner in TB nude mice; therefore, regulation of adipose triacylglycerol fatty acid mobilization (as plasma FFA) by dietary sugar is probably not affected by MX-1 tumor growth in these mice. Our findings are consistent with the hypothesis that nude mice may be unable to secrete TNF/cachectin in response to tumor growth, but they do not establish whether or not endogenous, circulating TNF/cachectin increases FFA mobilization in any TB animal.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 12 条
  • [1] EFFECT OF CATECHOLAMINES ON PLASMA-FREE FATTY-ACIDS IN FED AND FASTED CATTLE
    BLUM, JW
    KUNZ, P
    EXPERIENTIA, 1981, 37 (06): : 607 - 607
  • [2] EFFECTS OF CATECHOLAMINES ON PLASMA-FREE FATTY-ACIDS IN FED AND FASTED CATTLE
    BLUM, JW
    FROEHLI, D
    KUNZ, P
    ENDOCRINOLOGY, 1982, 110 (02) : 452 - 456
  • [3] EFFECT OF DIETARY-FAT AND FATTY-ACIDS ON LIVER LIPID-ACCUMULATION IN FASTED-REFED RATS
    AOYAMA, Y
    YOSHIDA, A
    ASHIDA, K
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1974, 38 (10): : 1791 - 1796
  • [4] TURNOVER AND FATE OF PLASMA-FREE FATTY-ACIDS IN BRIEFLY-FASTED LYMPHOMA-BEARING MICE
    BAKER, N
    GANELEPANO, M
    GUTHRIE, BA
    MEAD, JF
    LIPIDS, 1989, 24 (12) : 1028 - 1034
  • [5] COMPARISON OF ANTI-TUMOR ACTIVITIES OF NITROSOUREA DERIVATIVES AGAINST MAMMARY BREAST-CARCINOMA (MX-1) IN NUDE-MICE
    INOUE, K
    FUJIMOTO, S
    OGAWA, M
    GANN, 1980, 71 (05): : 686 - 691
  • [6] EVALUATION OF ANTITUMOR-ACTIVITY OF NORDIHYDROGUIARETIC ACID (NA) WITH HUMAN MAMMARY ADENOCARCINOMA XENOGRAFTS(MX-1) IN ATHYMIC NUDE-MICE
    ALLEN, LM
    WARA, W
    GONZAGA, A
    PARKHURST, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 329 - 329
  • [7] A novel antitubulin agent and its phosphate prodrug effective against MX-1 human mammary tumor xenografts in athymic nude mice.
    Schwendner, SW
    Hoffman, LA
    Thoolen, MJMC
    Timmermans, PBMWM
    CLINICAL CANCER RESEARCH, 1999, 5 : 3857S - 3857S
  • [8] Synergy of T138067-sodium in combination with cisplatin against MX-1 human mammary tumor xenografts in athymic nude mice.
    Schwendner, SW
    DiMaio, HK
    Hoffman, LA
    Stein, CK
    Thoolen, MJMC
    Timmermans, PBMWM
    CLINICAL CANCER RESEARCH, 1999, 5 : 3857S - 3858S
  • [9] ANTI-TUMOR EFFICACY OF 17 ANTI-CANCER DRUGS IN HUMAN-BREAST CANCER XENOGRAFT (MX-1) TRANSPLANTED IN NUDE-MICE
    INOUE, K
    FUJIMOTO, S
    OGAWA, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 182 - 186
  • [10] EFFECT OF GLUCOSE AND PLASMA-FREE FATTY-ACIDS ON HUMAN PLACENTAL LACTOGEN (HPL) CIRCULATING LEVELS IN LATE PREGNANCY
    GASPARD, UJ
    GEORGE, AN
    LAMBOTTE, R
    DIABETOLOGIA, 1976, 12 (04) : 392 - 392